Insights into FDA's controversial decision to approve a new Alzheimer's treatment drug

Health Affairs This Week - A podcast by Health Affairs - Fridays

Listen to Health Affairs' Rob Lott and Leslie Erdelack discuss the FDA's controversial decision to approve Aduhelm (aducanumab) to treat patients with Alzheimer's disease.